Program Leaders: Karen Glanz, PhD, MPH and Steven Joffe, MD, MPH
The Cancer Control Program is a highly collaborative and transdisciplinary Program that focuses on identifying and analyzing the genetic, behavioral, and health care determinants of cancer susceptibility and outcomes in diverse and vulnerable populations and on developing, evaluating and implementing interventions to lower risk and improve cancer outcomes. The Cancer Control Program is one of two Population Science Research Programs of the Abramson Cancer Center. Program members work intra- and inter-Programmatically to apply advances in science to population health and cutting-edge data analytics, address the cancer burdens and risk factors in our catchment area, and train the next generation of cancer control researchers. Members conduct research within four broad and interconnected Program aims:
- Advance the science of genetic susceptibility to cancer, the interaction between genes and environmental risk factors and their contribution to cancer risk, outcomes and disparities, and the fundamental methods underlying these scientific inquiries (cancer genomics and risk)
- Conduct transdisciplinary research, drawing upon communication science, cognitive and social psychology, economics, health behavior, and implementation of evidence-based strategies, that focuses on prevention and early detection of cancer (communication and health behavior)
- Grow the evidence base supporting clinical practice, focused on optimizing quality of life and reducing morbidity and mortality, for both pediatric and adult cancer survivors and on bridging the pediatric-to-adult divide in cancer care and late effects (cancer survivorship)
- Investigate models of cancer care and clinical trials in order to translate evidence into effective and equitable cancer care and to reduce cancer treatment disparities (health care outcomes)
Program members produced a substantial body of high impact work in recent years. In Cancer Genomics and Risk, members established the basis for clinical management of individuals with moderate penetrance risk genes for breast and colorectal cancer, identified risk loci associated with susceptibility to testicular germ cell tumors, and established the comparable efficacy of genetic counseling delivered through telehealth. In Communication and Health Behavior, members conducted innovative studies on the use of incentives for improving early detection and novel transdisciplinary research in diet, obesity and cancer. In Cancer Survivorship, members established clinical paradigms for cancer survivors through patient-centered care plans and revealed important complexities in end of life care. In Health Outcomes, members innovated methods to use the electronic health record to improve health behaviors and conducted pragmatic trials to innovate new models of high-quality cancer care. The Cancer Control Program is a vibrant community of interactive population science investigators working across four inter-connected aims to further research impacting our catchment area and beyond.
Cancer Control Program Membership
- David Asch, MD, MBA
- Justin Bekelman, MD
- Angela Bradbury, MD
- Tamara Cadet, PhD, LICSW, MPH
- Jinbo Chen, PhD
- Katherine Courtright, MD, MS
- Farouk Dako, MD, MPH
- Bart DeJonghe, PhD
- Jie Deng, PhD, RN
- Meredith Doherty, PhD, LCSW
- Emily Falk, PhD
- Alexander Fiks, MD, MSCE
- Kelly Getz, PhD, MPH
- Jill Ginsberg, MD
- Karen Glanz, PhD, MPH
- Surbhi Grover, MD, MPH
- Carmen Guerra, MD, MSCE
- Scott Halpern, MD, PhD, M.Bioethics
- Sean Hennessy, PharmD, PhD
- Rebecca Hubbard, PhD
- Linda Jacobs, PhD, CRNP
- Ravishankar Jayadevappa, PhD
- Steven Joffe, MD, MPH
- Bryson Katona, MD, PhD
- Rachel Kelz, MD, MSCE
- Roger Kim, MD, MSCE
- Emily Ko, MD, MSCR
- Melanie Kornides, ScD, RN, FNP-BC
- Robert Krouse, MD, MS
- Hongzhe Li, PhD
- Qi Long, PhD
- Ronac Mamtani, MD, MSCE
- Kara Maxwell, MD, PhD
- Anne Marie McCarthy, ScM, PhD
- Salimah Meghani, PhD, MBE, RN, FAAN
- Shivan Mehta, MD, MBA, MSHP
- Jeffrey Morris, PhD
- Katherine Nathanson, MD
- Ravi Parikh, MD, MPP, FACP
- Katharine Rendle, PhD, MSW, MPH
- Christina Roberto, PhD
- Marilyn Schapira, MD, MPH
- Lisa Schwartz, PhD, MA
- Jeffrey Silber, MD, PhD
- Kevin Volpp, MD, PhD
- Richard Wender, MD
- Gary Wu, MD
- Yu-Xiao Yang, MD, MSCE